Sciety

About The Fund

Sciety is an investor syndicate regarded as a leader in the Nordic region, focusing exclusively on life science and health tech sectors. Their investment philosophy blends their collective experience in both life science and finance to identify companies with high promise within their specific industry. They commit their own funds to all companies that successfully go through their rigorous selection process and additionally extend the opportunity for their network—comprised of venture capital firms, family offices, and business angels—to co-invest on identical terms. This democratization of investment opportunities is an integral part of their vision to ensure life science innovations achieve their full potential, thus benefiting society at large. Core investment areas for Sciety include biotechnology, pharmaceuticals, medical technology, and health technology. In line with their commitment, Sciety's website elaborates on their approach to contributing to a healthier world, whether their partners are investors seeking both returns and impact, or entrepreneurs aiming to take significant development steps. The firm emphasizes the importance of innovations in precision medicine, genomics, and the integration of technology in healthcare. They highlight not only the investment process but also the potential life-saving progress of the medical sector over the past century, showing their vested interest in health advancements. Sciety’s investment strategy isn't confined to financial input; their goal is to establish long-term partnerships. Their team of experts from diverse professional backgrounds, including research, medicine, entrepreneurship, and economics, supports portfolio companies to reach market growth. They also use a structured digital approach to manage their investments. Recognizing Sweden as a dynamic hub for life science innovation and observing the increasing demand for healthcare solutions, Sciety is active in supporting growth companies contributing to the surge in partnerships between major pharma and smaller firms and driving digital health solutions.